ArticleClinical transplantation and research2026
Efficacy of robot-assisted versus open kidney transplantation in obese patients: a systematic review and meta-analysis.
Article in Clinical transplantation and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity complicates open kidney transplantation (OKT), driving increasing interest in robot-assisted kidney transplantation (RAKT). This study compared intraoperative and postoperative outcomes of RAKT and OKT in patients with a body mass index ≥30 kg/m Methods: Systematic searches of PubMed, Scopus, and the Cochrane Library were conducted through April 15, 2025. Four retrospective cohort studies (147 RAKT and 625 OKT cases) met the inclusion criteria. Pooled analyses evaluated cold and warm ischemia times, estimated blood loss, estimated glomerular filtration rate (eGFR) at 6 months and 1 year, serum creatinine at 6 months and 3 years, delayed graft function (DGF), graft survival at 1 and 3 years, length of stay, rejection rate, 1-year patient survival, and surgical site infection (SSI) using a random-effects model. Results: No significant differences were observed in cold ischemia time (mean difference [MD], 43.88 minutes; 95% confidence interval [CI], -88.06 to 175.82 minutes; P=0.51), warm ischemia time (MD, 3.21 minutes; 95% CI, -3.23 to 9.65 minutes; P=0.33), or estimated blood loss (MD, -41.30 mL; 95% CI, -95.60 to 12.99 mL; P=0.14). Other postoperative outcomes, including graft function (eGFR and creatinine), DGF, hospital stay, rejection, and 1-year survival, were also comparable. However, RAKT was associated with a significantly lower SSI incidence (risk ratio, 0.14; 95% CI, 0.04-0.45; P=0.0009). Conclusions: In obese patients, RAKT yields outcomes comparable to OKT, with the added potential benefit of reducing SSI risk. Nonetheless, as most findings are based on very low-certainty evidence, these results should be interpreted with caution. Larger randomized trials are required to confirm these outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.